APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Selected research

Market Structure

Global Prostacyclin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025181 pages

Choose your research edition.

Industry ResearchProstacyclin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Prostacyclin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.

North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.

Read the full market overview

In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.

This report provides an overview of the global Prostacyclin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostacyclin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostacyclin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostacyclin market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostacyclin Segment by Company

United Therapeutics

Actelion (J & J)

GSK

Teva

Toray

Tide Pharma

Bayer AG

Prostacyclin Segment by Type

Epoprostenol Sodium

Treprostinil

Iloprost

Beraprost Sodium

Prostacyclin Segment by Application

For Injection

For Oral

For Inhalation

Prostacyclin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostacyclin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prostacyclin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prostacyclin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prostacyclin Industry Trends Table 2. Prostacyclin Industry Drivers Table 3. Prostacyclin Industry Opportunities and Challenges Table 4. Prostacyclin Industry Restraints Table 5. Global Prostacyclin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prostacyclin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prostacyclin Sales by Manufacturers (K Unit) & (2021-2026) Table 8. Global Prostacyclin Sales Market Share by Manufacturers Table 9. Global Prostacyclin Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Prostacyclin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prostacyclin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prostacyclin Manufacturers, Product Type & Application Table 13. Global Prostacyclin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostacyclin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Epoprostenol Sodium Table 17. Major Manufacturers of Treprostinil Table 18. Major Manufacturers of Iloprost Table 19. Major Manufacturers of Beraprost Sodium Table 20. Global Prostacyclin Sales by Type 2021 VS 2025 VS 2032 (K Unit) Table 21. Global Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 22. Global Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 23. Global Prostacyclin Sales Market Share by Type (2021-2026) Table 24. Global Prostacyclin Sales Market Share by Type (2027-2032) Table 25. Global Prostacyclin Revenue by Type 2021 VS 2025 VS 2032 (K Unit) Table 26. Global Prostacyclin Revenue by Type (2021-2026) & (K Unit) Table 27. Global Prostacyclin Revenue by Type (2027-2032) & (K Unit) Table 28. Global Prostacyclin Revenue Market Share by Type (2021-2026) Table 29. Global Prostacyclin Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of For Injection Table 31. Major Manufacturers of For Oral Table 32. Major Manufacturers of For Inhalation Table 33. Global Prostacyclin Sales by Application 2021 VS 2025 VS 2032 (K Unit) Table 34. Global Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 35. Global Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 36. Global Prostacyclin Sales Market Share by Application (2021-2026) Table 37. Global Prostacyclin Sales Market Share by Application (2027-2032) Table 38. Global Prostacyclin Revenue by Application 2021 VS 2025 VS 2032 (K Unit) Table 39. Global Prostacyclin Revenue by Application (2021-2026) & (K Unit) Table 40. Global Prostacyclin Revenue by Application (2027-2032) & (K Unit) Table 41. Global Prostacyclin Revenue Market Share by Application (2021-2026) Table 42. Global Prostacyclin Revenue Market Share by Application (2027-2032) Table 43. Global Prostacyclin Sales by Region: 2021 VS 2025 VS 2032 (K Unit) Table 44. Global Prostacyclin Sales by Region (2021-2026) & (K Unit) Table 45. Global Prostacyclin Sales Market Share by Region (2021-2026) Table 46. Global Prostacyclin Sales Forecasted by Region (2027-2032) & (K Unit) Table 47. Global Prostacyclin Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 49. North America Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 50. North America Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 51. Europe Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 52. Europe Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 53. Europe Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 54. Asia Pacific Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 55. Asia Pacific Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 56. Asia Pacific Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 57. South America, Middle East and Africa Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Unit) Table 58. South America, Middle East and Africa Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 59. South America, Middle East and Africa Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 60. Global Prostacyclin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Prostacyclin Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Prostacyclin Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Prostacyclin Revenue Market Share by Region (2021-2026) Table 64. Global Prostacyclin Revenue Market Share by Region (2027-2032) Table 65. United Therapeutics Company Information Table 66. United Therapeutics Business Overview Table 67. United Therapeutics Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. United Therapeutics Prostacyclin Product Portfolio Table 69. United Therapeutics Recent Development Table 70. Actelion (J & J) Company Information Table 71. Actelion (J & J) Business Overview Table 72. Actelion (J & J) Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Actelion (J & J) Prostacyclin Product Portfolio Table 74. Actelion (J & J) Recent Development Table 75. GSK Company Information Table 76. GSK Business Overview Table 77. GSK Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GSK Prostacyclin Product Portfolio Table 79. GSK Recent Development Table 80. Teva Company Information Table 81. Teva Business Overview Table 82. Teva Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Teva Prostacyclin Product Portfolio Table 84. Teva Recent Development Table 85. Toray Company Information Table 86. Toray Business Overview Table 87. Toray Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Toray Prostacyclin Product Portfolio Table 89. Toray Recent Development Table 90. Tide Pharma Company Information Table 91. Tide Pharma Business Overview Table 92. Tide Pharma Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Tide Pharma Prostacyclin Product Portfolio Table 94. Tide Pharma Recent Development Table 95. Bayer AG Company Information Table 96. Bayer AG Business Overview Table 97. Bayer AG Prostacyclin Sales (K Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Bayer AG Prostacyclin Product Portfolio Table 99. Bayer AG Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Prostacyclin Distributors List Table 103. Prostacyclin Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Prostacyclin Product Image Figure 2. Global Prostacyclin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostacyclin Sales (2021-2032) & (K Unit) Figure 5. Global Prostacyclin Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prostacyclin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Epoprostenol Sodium Image Figure 9. Treprostinil Image Figure 10. Iloprost Image Figure 11. Beraprost Sodium Image Figure 12. Global Prostacyclin Sales by Type (2021 VS 2025 VS 2032) & (K Unit) Figure 13. Global Prostacyclin Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Prostacyclin Sales Market Share by Type (2021-2032) Figure 15. Global Prostacyclin Revenue by Type (2021 VS 2025 VS 2032) & (K Unit) Figure 16. Global Prostacyclin Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Prostacyclin Revenue Market Share by Type (2021-2032) Figure 18. For Injection Image Figure 19. For Oral Image Figure 20. For Inhalation Image Figure 21. Global Prostacyclin Sales by Application (2021 VS 2025 VS 2032) & (K Unit) Figure 22. Global Prostacyclin Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Prostacyclin Sales Market Share by Application (2021-2032) Figure 24. Global Prostacyclin Revenue by Application (2021 VS 2025 VS 2032) & (K Unit) Figure 25. Global Prostacyclin Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Prostacyclin Revenue Market Share by Application (2021-2032) Figure 27. North America Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 28. North America Prostacyclin Sales Market Share by Country (2021-2032) Figure 29. U.S. Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 30. Canada Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 31. Mexico Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 32. Europe Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 33. Europe Prostacyclin Sales Market Share by Country (2021-2032) Figure 34. Germany Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 35. France Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 36. U.K. Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 37. Italy Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 38. Netherlands Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 39. Asia Pacific Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 40. Asia Pacific Prostacyclin Sales Market Share by Country (2021-2032) Figure 41. China Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 42. Japan Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 43. South Korea Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 44. Southeast Asia Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 45. India Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 46. Australia Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 47. South America, Middle East and Africa Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 48. South America, Middle East and Africa Prostacyclin Sales Market Share by Country (2021-2032) Figure 49. Brazil Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 50. South Africa Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 51. Saudi Arabia Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 52. Turkey Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 53. Argentina Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 54. UAE Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 55. Egypt Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 56. Chile Prostacyclin Sales and Growth Rate (2021-2032) & (K Unit) Figure 57. Global Prostacyclin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Prostacyclin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Prostacyclin Revenue (2021-2032) & (US$ Million) Figure 60. North America Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Prostacyclin Revenue (2021-2032) & (US$ Million) Figure 62. Europe Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Prostacyclin Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Prostacyclin Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Prostacyclin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prostacyclin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
  • Beraprost Sodium
Applications
  • For Injection
  • For Oral
  • For Inhalation
Companies covered
  • United Therapeutics
  • Actelion (J & J)
  • GSK
  • Teva
  • Toray
  • Tide Pharma
  • Bayer AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostacyclin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostacyclin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prostacyclin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prostacyclin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prostacyclin Market Dynamics
  1. 2.1 Prostacyclin Industry Trends
  2. 2.2 Prostacyclin Industry Drivers
  3. 2.3 Prostacyclin Industry Opportunities and Challenges
  4. 2.4 Prostacyclin Industry Restraints
3 Prostacyclin Market by Manufacturers
  1. 3.1 Global Prostacyclin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prostacyclin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prostacyclin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prostacyclin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostacyclin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prostacyclin Manufacturers, Product Type & Application
  7. 3.7 Global Prostacyclin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostacyclin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostacyclin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostacyclin Tier 1, Tier 2, and Tier 3
4 Prostacyclin Market by Type
  1. 4.1 Prostacyclin Type Introduction
  2. 4.1.1 Epoprostenol Sodium
  3. 4.1.2 Treprostinil
  4. 4.1.3 Iloprost
  5. 4.1.4 Beraprost Sodium
  6. 4.2 Global Prostacyclin Sales by Type
  7. 4.2.1 Global Prostacyclin Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prostacyclin Sales by Type (2021-2032)
  9. 4.2.3 Global Prostacyclin Sales Market Share by Type (2021-2032)
  10. 4.3 Global Prostacyclin Revenue by Type
  11. 4.3.1 Global Prostacyclin Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prostacyclin Revenue by Type (2021-2032)
  13. 4.3.3 Global Prostacyclin Revenue Market Share by Type (2021-2032)
5 Prostacyclin Market by Application
  1. 5.1 Prostacyclin Application Introduction
  2. 5.1.1 For Injection
  3. 5.1.2 For Oral
  4. 5.1.3 For Inhalation
  5. 5.2 Global Prostacyclin Sales by Application
  6. 5.2.1 Global Prostacyclin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostacyclin Sales by Application (2021-2032)
  8. 5.2.3 Global Prostacyclin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prostacyclin Revenue by Application
  10. 5.3.1 Global Prostacyclin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prostacyclin Revenue by Application (2021-2032)
  12. 5.3.3 Global Prostacyclin Revenue Market Share by Application (2021-2032)
6 Global Prostacyclin Sales by Region
  1. 6.1 Global Prostacyclin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostacyclin Sales by Region (2021-2032)
  3. 6.2.1 Global Prostacyclin Sales by Region (2021-2026)
  4. 6.2.2 Global Prostacyclin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prostacyclin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prostacyclin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prostacyclin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prostacyclin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prostacyclin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prostacyclin Revenue by Region
  1. 7.1 Global Prostacyclin Revenue by Region
  2. 7.1.1 Global Prostacyclin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prostacyclin Revenue by Region (2021-2026)
  4. 7.1.3 Global Prostacyclin Revenue by Region (2027-2032)
  5. 7.1.4 Global Prostacyclin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prostacyclin Revenue (2021-2032)
  8. 7.2.2 North America Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prostacyclin Revenue (2021-2032)
  11. 7.3.2 Europe Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prostacyclin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prostacyclin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prostacyclin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 United Therapeutics
  2. 8.1.1 United Therapeutics Company Information
  3. 8.1.2 United Therapeutics Business Overview
  4. 8.1.3 United Therapeutics Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 United Therapeutics Prostacyclin Product Portfolio
  6. 8.1.5 United Therapeutics Recent Developments
  7. 8.2 Actelion (J & J)
  8. 8.2.1 Actelion (J & J) Company Information
  9. 8.2.2 Actelion (J & J) Business Overview
  10. 8.2.3 Actelion (J & J) Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Actelion (J & J) Prostacyclin Product Portfolio
  12. 8.2.5 Actelion (J & J) Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Prostacyclin Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Teva
  20. 8.4.1 Teva Company Information
  21. 8.4.2 Teva Business Overview
  22. 8.4.3 Teva Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Prostacyclin Product Portfolio
  24. 8.4.5 Teva Recent Developments
  25. 8.5 Toray
  26. 8.5.1 Toray Company Information
  27. 8.5.2 Toray Business Overview
  28. 8.5.3 Toray Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Toray Prostacyclin Product Portfolio
  30. 8.5.5 Toray Recent Developments
  31. 8.6 Tide Pharma
  32. 8.6.1 Tide Pharma Company Information
  33. 8.6.2 Tide Pharma Business Overview
  34. 8.6.3 Tide Pharma Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tide Pharma Prostacyclin Product Portfolio
  36. 8.6.5 Tide Pharma Recent Developments
  37. 8.7 Bayer AG
  38. 8.7.1 Bayer AG Company Information
  39. 8.7.2 Bayer AG Business Overview
  40. 8.7.3 Bayer AG Prostacyclin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer AG Prostacyclin Product Portfolio
  42. 8.7.5 Bayer AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostacyclin Value Chain Analysis
  2. 9.1.1 Prostacyclin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostacyclin Production Mode & Process
  6. 9.2 Prostacyclin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostacyclin Distributors
  9. 9.2.3 Prostacyclin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst